Ricovr’s proprietary Plasmonic Fiber-Optic Absorbance Biosensor (P-FAB) is a portable, ultra-sensitive detection engine designed to identify any analyte—from drugs to hormones – with a single, non-invasive saliva sample.
Ricovr’s P-FAB platform uses a U-bent optical fiber to amplify the interaction between light and target biomarkers at the sensor surface. As light travels through the bend, it creates an evanescent field that is highly sensitive to molecular binding events. This enables rapid, direct detection from saliva without the complexity of traditional laboratory workflows.
P-FAB is designed to bring high-sensitivity biomarker detection out of the lab and into real-world testing environments. By combining advanced fiber-optic sensing with a portable reader and disposable cartridge format, Ricovr can deliver precise, digital results at the point of need.
Ricovr’s approach reduces the need for complex wash steps, helping simplify the testing workflow and making the technology better suited for point-of-care use.
| Capability | Traditional Lab Test | Traditional Field Tests | RICOVR P-FAB |
|---|---|---|---|
| Saliva-based collection | Limited | Yes | Yes |
| Portable point-of-care format | No | Yes | Yes |
| High-sensitivity detection | Yes | Limited | Yes |
| Digital result interpretation | Yes | Limited | Yes |
| Minimal workflow complexity | No | Yes | Yes |
| Scalable multi-analyte platform | Limited | Limited | Yes |
Ricovr’s first application, XALIVA™ THC, demonstrates the power of the P-FAB platform in one of the most challenging and urgent testing categories: recent cannabis use detection. As cannabis legalization expands, employers and safety-sensitive organizations need a better way to make timely, fair, and objective decisions.
XALIVA™ THC – A rapid saliva-based test designed to detect recent THC use at the point of need, helping organizations modernize workplace and public safety testing.
Ricovr’s platform is designed as a scalable diagnostic engine, not a single-test product. The same core P-FAB technology can be adapted across multiple analytes and use cases by changing the assay chemistry and cartridge design.
A single portable reader can support a pipeline of cartridge-based tests, allowing Ricovr to expand from THC into broader drug panels, clinical biomarkers, women’s health, and infectious disease applications.